Internal Medicine, Endocrinology, Diabetes, & Metabolism · Gadsden, AL
NPI
1982665980
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
100 Medical Center Dr, Suite #305
Gadsden, AL, 35903
Phone (256) 494-0990
Groups this clinician bills Medicare through
Medicare paid, 2024
$53K
818 services
Medicare patients, 2024
274
Average age 73
Drug cost, 2024
$3.3M
6,386 prescriptions
Company payments, 2025
$1,401
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Dominic F Homan was code 99214 (office e&m - established), 549 times for 249 patients. In total Dominic F Homan billed 818 services in 7 codes, and Medicare paid $53K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 549 | 249 | $84.25 | $46K |
| 83036 Blood Count | Office | 215 | 135 | $9.45 | $2,031 |
| 99203 Office E&M - New | Office | 26 | 26 | $69.72 | $1,813 |
| 99205 Office E&M - New | Office | 16 | 16 | $154.29 | $2,469 |
By year: 2022 $66K for 1,124 services; 2023 $54K for 867 services; 2024 $53K for 818 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 215 | 135 | $9.45 | $2,031 |
Medicare prescription drug claims, 2024
In 2024, the drug Dominic F Homan prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 510 prescriptions and refills. In total Dominic F Homan wrote 6,386 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 510 | 947 | 126 | $510K |
| Levothyroxine Sodium Generic | 371 | 1,045 | 104 | $8,739 |
| Januvia Sitagliptin Phosphate | 246 | 438 | 51 | $220K |
| Metformin Hcl Generic | 242 | 680 | 78 | $2,051 |
| Mounjaro Tirzepatide | 200 | 294 | 43 | $310K |
| Jardiance Empagliflozin | 193 | 388 | 46 | $219K |
| Atorvastatin Calcium Generic | 180 | 504 | 58 | $3,490 |
| Rosuvastatin Calcium Generic | 170 | 440 | 50 | $3,793 |
| Ozempic Semaglutide | 161 | 268 | 44 | $244K |
| Tresiba Flextouch U-100 Insulin Degludec | 148 | 313 | 36 | $140K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 146 | 336 | 41 | $36K |
| Glimepiride Generic | 127 | 329 | 31 | $1,937 |
| Trulicity Dulaglutide | 126 | 173 | 28 | $166K |
| Pioglitazone Hcl Generic | 125 | 349 | 37 | $2,492 |
| Ezetimibe Generic | 119 | 344 | 40 | $4,118 |
Brand drugs: 3,393 claims; generic drugs: 2,609 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Dominic F Homan $1,401 ($1,401 in general payments such as food, travel and fees) from 18 companies. The largest payer was Novo Nordisk Inc with $273.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 10 | $273 |
| Lilly USA, LLC LLY | 10 | $176 |
| Abbott Laboratories ABT | 15 | $167 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $135 |
| Amgen Inc. AMGN | 5 | $111 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $90.43 |
| Abbvie Inc. ABBV | 3 | $60.28 |
| Xeris Pharmaceuticals, Inc. | 3 | $57.75 |
| Insulet Corporation PODD | 2 | $52.39 |
| Corcept Therapeutics CORT | 2 | $49.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.